slide1 l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Medizinische Hochschule Hannover Carl-Neuberg Straße 1 30625 Hannover Telefon: 0511-532 6760 hoerning.monique@mh-hannov PowerPoint Presentation
Download Presentation
Medizinische Hochschule Hannover Carl-Neuberg Straße 1 30625 Hannover Telefon: 0511-532 6760 hoerning.monique@mh-hannov

Loading in 2 Seconds...

play fullscreen
1 / 2

Medizinische Hochschule Hannover Carl-Neuberg Straße 1 30625 Hannover Telefon: 0511-532 6760 hoerning.monique@mh-hannov - PowerPoint PPT Presentation


  • 200 Views
  • Uploaded on

Lunch 11.45 – 13.00 13.00-13.25 Siveke J. Molecular mechanism of tumor development in a mouse model of pancreatic cancer 13.25-13.50 Bruns C Angiogenesis and metastasis regulating genes in pancreatic cancer 13.50-14.15 Lechel A.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Medizinische Hochschule Hannover Carl-Neuberg Straße 1 30625 Hannover Telefon: 0511-532 6760 hoerning.monique@mh-hannov' - clifton


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

Lunch 11.45 – 13.00

13.00-13.25 Siveke J.

Molecular mechanism of tumor development in a mouse model of pancreatic cancer

13.25-13.50 Bruns C

Angiogenesis and metastasis regulating genes in

pancreatic cancer

13.50-14.15 Lechel A.

Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease

14.15-14.40 Müller-Schilling M.

Molecular mechanisms of p53/p63 and p73 in

hepatocarinogenesis

14.40-15.05 Malek N.P.

Control of cell cycle progression and tissue

homeostasis by p27 and cyclin E

Location:

Eibsee Hotel

Am Eibsee 1-3D-82491 GrainauPhone: +49-(0)8821-98810

Distance:Grainau: 3 kmGarmisch-Partenkirchen: 11 km München: 97 kmInnsbruck: 68 kmFüssen: 59 km

Molecular pathogenesis and experimental therapy of gastrointestinal cancer –

07.March - 09. March 2007

Contact Information

Medizinische Hochschule Hannover

Carl-Neuberg Straße 1

30625 Hannover

Telefon: 0511-532 6760

hoerning.monique@mh-hannover.de

Achtung! Farbwechsel des Vordrucks beachten! An diese Stelle keinen Text stellen!

slide2

State of the art lecture: Molecular pathways of genomic instability

Division of Molecular Biology, The Netherlands Cancer Institute:

15.05-15.45 Jos Jonkers

Molecular pathways of genomic instability in

cancer formation

Coffee break 15.45-16.15

Immunology and Virotherapy

16.15-16.40 Zender L.

Impact of senescence on innate immunity in a HCC mouse model

16.40-17.05 Greten T.

Role of Tregs and tumor cell death in immunotherapy of HCC

17.05-17.30 Gütgemann I.

A new model for antigen recognition in hepatocellular carcinoma: LAPtTA x c- MYC/OVA transgenic mice

17.30-17.55 Becker P.

Strategies for immune-intervention

17.55-18.20 Ebert O.

Treatment of hepatocellular carcinoma with tumor specific replicating visicular stomatitis virus

18.20-18.45 Kubicka S.

Migration and expansion of dendritic cells as a tool for enhanced crosspresentation of tumorantigens by tumorspecific replicating viruses (Viro- Immunotherapy)

19.30-20.00 Walk with torchlight

20.00 Rustic buffet in the Eibsee cottage

Friday 9th March

Breakfast 7.00-8.00

State of the art lecture: Academic drug development

Medical School Hannover and HZI:

8.00-8.15 Malek N.P.

Academic drug development for targeted therapy of cancer – part I

8.15-8.30 Kalesse M.

Academic drug development for targeted therapy of cancer – part II

8.30-8.45 Frank R.

Academic drug development for targeted therapy of cancer – part III

New experimental therapies:

8.45-9.10 Mier W.

Endoradiotherapeutic procedures as a tool for tumor therapy

9.10-9.35 Ganten T.

The promise of Trail – potential and risks of novel anti cancer therapy

9.35-10.00 de Toni E.

Sensitising of cancer cells for receptor-mediated

apoptosis: new therapeutic approach for HCC

Coffee break 10.00-10.30

Molecular biology

10.30-10.55 Breuhahn, K.

Dysregulation of FUSE-binding transcription

factors in hepatocarcinogenesis

10.55-11.20 Zender L.

New mir30RNA libraries and comparative

oncogenomics in GI oncology

11.20-11.45 Schneider G.

Cell cycle regulation in Pancreatic cancer cells

Thursday 8th March

Cell biology and metabolism

Breakfast 7.30 – 8.00

8.00-8.25 Straub B.

A new form of cell contact: cis-E:N-Cadherin hybrids in normal and malignant liver cells

8.25-8.50 Skawran B.

Chromatin remodeling and induction of chromosomal instability

8.50-9.15 Kern M.

Prostaglandin metabolism in hepatocarcinogenesis

9.15-9.40 Nies A.

Localisation and function of transmembrane transporters in HCC

9.40-10.05 Ryschich E.

Time laps microscopy for investigation of tumor cell migration

Virology

10.05-10.30 Urban S.

HepaRG-cells as a tool to study HBV-infection as well as hepatocyte-specific differentiation and polarization processes

10.30-11.00 Bartenschlager R.

Strategies of hepatitis C virus replication and persistence

Genomics

11.00-11.25 Radlwimmer B.

Array-CGH and gene methylation in HCC

11.25-11.50 Geffers R.

Role of SNPs in carcinogenesis and cancer

therapy

13.50-14.15 Gallmeier E

DNA-repair gene alterations as a pharmacogenomic target for the treatment of

GI cancer

14.15-14.40 Kolligs F

Critical genes for development of colorectal

cancer: new therapeutic targets? 

14.40-15.05 Singer S.

Mikrotubuli destabilising proteins as therapeutic targets for hepatocellular carcinoma

Lunch 11.50 – 13.50

Potential therapeutic targets